Level Biotechnology Inc. announced earnings results for the second quarter and half year ended June 30, 2021. For the second quarter, the company announced sales was TWD 182.337 million compared to TWD 166.600 million a year ago. Operating income was TWD 18.218 million compared to TWD 16.672 million a year ago. Net income was TWD 15.636 million compared to TWD 14.546 million a year ago. Basic earnings per share from continuing operations was TWD 0.48 compared to TWD 0.45 a year ago. For the half year, sales was TWD 344.361 million compared to TWD 300.486 million a year ago. Operating income was TWD 38.973 million compared to TWD 24.853 million a year ago. Net income was TWD 34.025 million compared to TWD 22.385 million a year ago. Basic earnings per share from continuing operations was TWD 1.05 compared to TWD 0.69 a year ago. Diluted earnings per share from continuing operations was TWD 1.04 compared to TWD 0.69 a year ago.